Apremilast
Apremilast is an orally administered small-molecule compound that functions as a selective inhibitor of phosphodiesterase 4 (PDE4). It is used as an active pharmaceutical ingredient in the manufacturing of medications for certain inflammatory conditions.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 608141-41-9
O-Demethyl apremilast
Pharmaceutical intermediate for apremilast
O3-Desethyl Apremilast
Pharmaceutical intermediate for Apremilast metabolite
2,2,2-trideuterio-N-(4-hydroxyphenyl)acetamide
active pharmaceutical ingredient
Tasimelteon
melatonin receptor agonist
4-Hydroxymethyl Loratadine
pharmaceutical impurity reference standard
Dibucaine hydrochloride
local anesthetic active pharmaceutical ingredient
Acetamide, N-[2-[(1S)-1-(3,4-dihydroxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-
pharmaceutical intermediate
N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide
IMOZEMNVLZVGJZ-QGZVFWFLSA-N
CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC